NIH/NIMH Research News Update 09-04-09

On September 4, 2009, in Medical Science, submitted by Christopher Fisher, PhD

The National Institutes of Health/Mental Health (NIH/NIMH) Research News Update for early September highlights that a combined atypical antipsychotic medication and an selective serotonin reuptake inhibitor (SSRI) may be the most effective treatment for psychotic depression, a new study that will investigate the transition from teenage years into adulthood for Autistic youth, new genetic research that links schizophrenia to changes in the fetal brain, several new studies on HIV, and more.

Here is the NIH/NIMH Research News Update for 09-04-09:

Enjoy.

CFisher

Related posts that you might enjoy:

About the author

Christopher Fisher, PhD

Dr. Christopher Fisher, Managing Editor for The Behavioral Medicine Report, received his PhD in Clinical Health Psychology & Behavioral Medicine with an emphasis in biopsychosocial approaches to health and wellness, Cognitive Behavioral Therapy (CBT), neurofeedback, biofeedback, cranial electrical stimulation (CES), and QEEG from University of North Texas. He is Board Certified in Neurofeedback (BCIA). Dr. Fisher also received a master’s degree in Clinical Psychology from Texas A&M-Corpus Christi. Dr. Fisher maintains a private practice in Corpus Christi, Texas, and offers individual therapy, group therapy, and neurofeedback. You can learn more here: http://www.christopherfisherphd.com Dr. Fisher enjoys spending time with family, watching sports and movies, and bicycling on rugged terrain.

Visit Authors Website